Efficacy and cost-effectiveness analysis of oral diclofenac sodium 3 days, 7 days for conventional radiofrequency denervation in the treatment of chronic facet joint pain: double-blinded randomised controlled trial

ISRCTN ISRCTN68542008
DOI https://doi.org/10.1186/ISRCTN68542008
Secondary identifying numbers N/A
Submission date
23/08/2008
Registration date
12/09/2008
Last edited
09/05/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Ma Ke
Scientific

Department of Anaesthesiology and Pain Centre
Shanghai Sixth People's Hospital
Shanghai Jiao Tong University
600 Yi-Shan Road
Shanghai
200233
China

Study information

Study designProspective, double-blinded, randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific title
Study objectives1. Diclofenac sodium can decrease the pain degree, and improve the patient's satisfaction after conventional radiofrequency denervation
2. Compared to 7 days dosage, 3 days diclofenac sodium therapeusis has the same efficacy and better cost-effectiveness for the treatment of pain after conventional radiofrequency denervation
Ethics approval(s)Ethics Committee of Shanghai Sixth People's Hospital, Shanghai Jiaotong University. Date of approval: 20/08/2008
Health condition(s) or problem(s) studiedChronic low back facet joints pain
InterventionArm 1: Placebo 3 times daily (tid) for 7 days
Arm 2: Diclofenac sodium 25 mg tid for 3 days and placebo tid for following 4 days
Arm 3: Diclofenac sodium 25 mg tid for 7 days

Total duration of treatment: 7 days
Total duration of follow-up: 60 days
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Diclofenac sodium
Primary outcome measure1. Pain, measured by a visual analogue scale (VAS) at baseline, Day 7, 14, 30, 60
2. Oswestry Disability Index (ODI) at baseline, Day 30 and 60
3. Cost-effectiveness analysis at 60 days
Secondary outcome measures1. Overall patients' satisfaction, measured by Patients' Satisfaction Score (3: excellent; 2: good; 1: moderate; 0: bad) at Day 60
2. Number needed to treat (NNT) to obtain one patient with good or complete pain relief at Day 60
3. Dosage of rescue drug. Duration of follow-up: 60 days after radiofrequency denervation.
4. Presence, frequency and duration of adverse effects at Day 7, 14, 30, 60
Overall study start date03/09/2008
Completion date30/03/2009

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants66
Key inclusion criteria1. Both males and females, age greater than 18 years
2. Duration of facet joints pain more than 6 months
3. Oswestry disability index 20%+
4. Unresponsiveness to traditional conservative treatments such as bed rest, medication, physical therapy, trigger point injection and epidural block
Key exclusion criteria1. Prior radiofrequency treatment
2. Coagulation disturbances
3. Allergies to local anaesthetic
4. Malignancy
5. Mental handicap or psychiatric condition precluding adequate communication, language problems
7. Unstable medical or psychiatric condition
8. Pregnancy
9. No effect of diagnostic blockades (one or two)
10. Gastrointestinal tract ulcer
11. Radicular syndrome
12. Indication for low back surgery
Date of first enrolment03/09/2008
Date of final enrolment30/03/2009

Locations

Countries of recruitment

  • China

Study participating centre

Department of Anaesthesiology and Pain Centre
Shanghai
200233
China

Sponsor information

Shanghai Sixth People's Hospital (China)
Hospital/treatment centre

Department of Anaesthesiology and Pain Centre
Shanghai Sixth People's Hospital
Shanghai JiaoTong University
600 Yi-Shan Road
Shanghai
200233
China

ROR logo "ROR" https://ror.org/049zrh188

Funders

Funder type

Hospital/treatment centre

Shanghai Sixth People's Hospital Clinical Research Fund (China)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/01/2011 Yes No